Global Neurostimulation Research Report 2023: An $11.7 Billion Market by 2028 – M&A Activity, Emerging Technologies and Developments, Competitive Landscape

DUBLIN, Dec. 14, 2023 /PRNewswire/ — The “Neurostimulation: Technologies and Global Markets” report has been added to  ResearchAndMarkets.com’s offering.

This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.

The human nervous system works as the chief commander of the human body. The medical science community has long believed that it has huge potential in treatment of human body disorders. Neurostimulation technology involves the alteration or modulation of nerves. Neurostimulation devices deliver electrical current or magnetic impulses directly to nerves in order to modify their activity.

Over the past 25 to 30 years, neurostimulation has emerged as one of the most dynamic fields of therapy, and has been actively investigated for treatment of a range of clinical conditions including chronic pain, movement disorders (Parkinson’s disease, tremor, dystonia and others), epilepsy, psychiatric disorders, functional restoration, cardiovascular disorders, gastrointestinal disorders and genitourinary disorders. It is also said to consist of “drug-free solutions.” Currently, the potential of neurostimulation technology is actively being explored for other clinical conditions including obesity, tinnitus and central nerve system disorders.

Given the vast size of the potential treatment population and the many ongoing scientific discoveries and technological advances in neurostimulation technologies, the market for neurostimulation devices market is poised for significant growth. Other factors expected to aid in the market boom include many countries’ growing elderly populations and increasing trends toward the use of nondrug therapies, greater expectations for quality of life, and improved patient attitudes toward receiving medical attention.

Neurostimulation technologies represent a cutting-edge field in neuroscience and medical science, aiming to modulate the activity of the nervous system to treat a wide range of neurological and neuropsychiatric disorders. These innovative techniques involve the application of electrical, magnetic or optogenetic stimuli to specific areas of the brain or nervous system, offering the potential to alleviate symptoms, restore lost function and enhance cognitive capabilities.

Neurostimulation is based on the concept of neuromodulation, where electrical signals are applied to neurons to alter their activity and influence neural networks. Neurons communicate through electrical impulses, and by selectively stimulating or inhibiting specific neural populations, neuroscientists and clinicians can modulate brain function.

This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson’s disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.

Report Includes

Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseasesDetailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantagesInformation on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapiesCoverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policiesMarket share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growthMarket share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies

Comprehensive company profiles of major players

Axonics IncBoston Scientific CorpMedtronic PLCSynapse Biomedical IncXavant Technology

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Overview of NeurostimulationTypes of Neurostimulation TechnologiesSpinal Cord StimulationDeep Brain StimulationSacral Nerve Stimulation (Sns)Vagus Nerve StimulationHypoglossal Nerve StimulationTranscutaneous Electrical Nerve StimulationTranscranial Magnetic Stimulation (Tms)Other Neurostimulation TechnologiesTherapeutic Applications for NeurostimulationChronic Pain ManagementNeurological DisordersUrinary and Fecal IncontinenceObstructive Sleep ApneaChronic Migraine and HeadacheCardiovascular DiseasesGastrointestinal DisordersObesityPsychiatric DisordersTechnological DevelopmentsMri CompatibilityRechargeable and Non-Rechargeable Devices

Chapter 4 Market Dynamics

Market TrendsDriversMarket Restraints

Chapter 5 Market Breakdown by Technology/Device Type

Global Market for Neurostimulation Devices by TypeSpinal Cord Stimulation (Scs) DevicesTranscutaneous Electrical Nerve Stimulation (Tens) DevicesDeep Brain Stimulation (Dbs) DevicesSacral Nerve Stimulation (Sns) DevicesVagus Nerve Stimulation (Vns) DevicesHypoglossal Nerve Stimulation (Hgns) DevicesMarket Size and ForecastTranscranial Magnetic Stimulation (Tms) DevicesOther Types of Neurostimulation Devices

Chapter 6 Market Breakdown by Therapeutic Application

Global Market for Neurostimulation Devices by Therapeutic ApplicationChronic PainUrinary and Fecal IncontinenceParkinson’s DiseaseEpilepsyObstructive Sleep Apnea (Osa)Essential TremorMajor Depressive Disorder (Mdd)/Clinical DepressionObsessive Compulsive Disorder (Ocd)Other Therapeutic Applications

Chapter 7 Market Breakdown by Region

Global Market for Neurostimulation Devices by RegionNorth AmericaEuropeAsia-PacificRest of the World

Chapter 8 Regulatory Structure

Regulatory FrameworkU.S.European UnionJapan

Chapter 9 Key Products and Technologies on the Market

Recent Therapeutic Improvements and New IndicationsSpinal Cord StimulationDeep Brain StimulationSacral Nerve Stimulation (Sns)AxonicsMedtronicVagus Nerve StimulationHypoglossal Nerve StimulationTranscutaneous Electrical Nerve StimulationTranscranial Magnetic StimulationOther Types of StimulationNew Indications and Neurostimulation Therapies

Chapter 10 Emerging Technologies and Developments

Emerging Technologies and DevelopmentsClosed-Loop NeurostimulationNon-Invasive Brain Stimulation TechniquesHigh-Frequency StimulationMagnetic Resonance-Guided Focused UltrasoundOptogeneticsBioelectronic MedicineWireless and Remote-Controlled Devices

Chapter 11 Recent M&A

M&A in the Neurostimulation Technologies Industry

Chapter 12 Competitive Landscape

Company Market Shares by Product SegmentSpinal Cord Stimulation DevicesDeep Brain Stimulation DevicesSacral Nerve Stimulation DevicesVagus Nerve Stimulation DevicesHypoglossal Nerve Stimulation DevicesTranscranial Magnetic Stimulation DevicesTranscutaneous Electrical Nerve Stimulation DevicesRecent Industry Activities

Chapter 13 Company Profiles

Abbott LaboratoriesAleva Neurotherapeutics SaAvery Biomedical Devices Inc.Axonics Inc.Bioinduction Ltd.Bioventus LLCBiowave Corp.Boston Scientific Corp.Brainsway Ltd.Cochlear AmericasCvrx Inc.Electrocore Inc.Inspire Medical Systems Inc.Integer Holdings Corp.Laborie Inc.Livanova plcMag & More GmbHMagstim Inc.Medtronic plcNalu Medical Inc.Neuromed Consulting Inc.Neurometrix Inc.Neuronetics Inc.Neuropace Inc.Neurosigma Inc.Neurovalens Ltd.Nevro Corp.Nexstim plcNyxoah SaSoterix Medical Inc.Synapse Biomedical Inc.Xavant Technology (Pty) Ltd.Zoll Medical Corp.

For more information about this report visit https://www.researchandmarkets.com/r/92nznn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-neurostimulation-research-report-2023-an-11-7-billion-market-by-2028—ma-activity-emerging-technologies-and-developments-competitive-landscape-302015122.html

SOURCE Research and Markets